Sec. 1139. SCHEDULING OF HYDROCODONE

177 words·~1 min read·/statute-compilations/comps-9932/sec-1139

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 1139 SCHEDULING OF HYDROCODONE ###

(a)In General Not later than 60 days after the date of enactment of this Act, if practicable, the Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall hold a public meeting to solicit advice and recommendations to assist in conducting a scientific and medical evaluation in connection with a scheduling recommendation to the Drug Enforcement Administration regarding drug products containing hydrocodone, combined with other analgesics or as an antitussive. ###

(b)Stakeholder Input In conducting the evaluation under subsection (a), the Secretary shall solicit input from a variety of stakeholders including patients, health care providers, harm prevention experts, the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and the Drug Enforcement Administration regarding the health benefits and risks, including the potential for abuse and the impact of up-scheduling of these products. ###

(c)Transcript The transcript of any public meeting conducted pursuant to this section shall be published on the Internet Web site of the Food and Drug Administration.